Mesoblast Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other companies in this sector in AUSTRALIA : Clinuvel Pharmaceuticals Limited (2019 sales of 31.61 million Australian Dollars [US$19.16 million] of which 100% was Biotechnology), Benitec Biopharma Limited (16.60 million Australian Dollars [US$10.06 million] ), and Cogstate Ltd (30.58 million Australian Dollars [US$18.53 million] of which 98% was Clinical Trials).

Sales Analysis. During the year ended June of 2019, sales at Mesoblast Ltd were A$23.40 million (US$14.18 million). This is an increase of 4.4% versus 2018, when the company's sales were A$22.42 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, Mesoblast Ltd had sales of A$25.98 million.